Ignite Creation Date:
2024-05-05 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 9:41 AM
Study NCT ID:
NCT00591370
Status:
COMPLETED
Last Update Posted:
2023-07-25
First Post:
2007-12-26
Brief Title:
Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center